Dr. Lyndsey Harper, an OB-GYN, has been named one of Forbes’ Top 53 Women Disrupting Healthcare. She is the founder and CEO of Rosy, a women’s health technology company dedicated to providing research-backed solutions for sexual health concerns. The underfunding and underdevelopment of women’s health issues have been a longstanding problem, often overshadowed by more urgent and reproductive-related health matters. As an advocate for women’s health, Dr. Harper aims to bridge the gap between physicians and health innovators to bring about positive changes in the healthcare industry, particularly in the realm of women’s health.
Over the years, women’s health research has seen minimal focus compared to other areas of healthcare. Despite the passing of the NIH Revitalization Act of 1993, which required the inclusion of women and minorities in clinical research trials, studies in women’s health have not adequately addressed their specific needs. The use of oral contraceptives as a one-size-fits-all treatment for various gynecological conditions, including endometriosis and irregular periods, is an example of how women’s health needs have been overlooked.
Endometriosis, a condition affecting over 10% of women, continues to lack non-invasive diagnostic methods, often leading to delayed and inadequate treatment. Additionally, sexual health issues in women, including low desire and pain during intercourse, are frequently overlooked and stigmatized. The lack of FDA-approved medications for women’s sexual health further exacerbates this disparity. These issues highlight the urgent need to invest in targeted research and treatments for women’s health concerns.
The current state of women’s health reflects a dire need for change. Dr. Harper advocates for a collaborative approach between healthcare innovators and physicians to address these challenges. She emphasizes the importance of women’s health startups in providing personalized solutions to address unmet needs. However, the lack of funding and data to support these interventions presents a significant barrier. Without adequate research, many women are left without evidence-based answers to their health concerns, resulting in frustration for both patients and physicians.
To address these challenges, Dr. Harper calls for a collaborative effort between health innovators and physicians. She emphasizes the need for both parties to work together to fill the gaps in women’s health research and care. By pooling resources and expertise, both groups can contribute to meaningful advancements in women’s health. This collaborative solution aims to create a more supportive and cohesive ecosystem that prioritizes the comprehensive healthcare needs of women.
In conclusion, Dr. Lyndsey Harper’s advocacy for collaborative efforts in women’s health is a crucial step towards addressing the longstanding disparities in this field. By fostering partnerships between healthcare innovators and physicians, the healthcare industry can work towards developing evidence-based solutions that meet the specific needs of women. This collaborative approach represents a beacon of hope for the future of women’s health, promising a more inclusive and comprehensive healthcare landscape.
